Dosage forms and related therapies

Details for Australian Patent Application No. 2003258909 (hide)

International Classifications

Event Publications

13 November 2003 Complete Application Filed

Priority application(s): 520897 20.08.02 NZ; 524795 17.03.03 NZ; 524796 17.03.03 NZ; 520895 20.08.02 NZ; 520896 20.08.02 NZ; 524794 17.03.03 NZ

22 April 2004 Application Open to Public Inspection

Published as AU-B-2003258909

24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

13 May 2010 Section 223 Application Received

Protemix Corporation Limited An application to extend the time from 19 Nov 2009 to 19 Jul 2010 in which to gain acceptance has been filed . Address for service in Australia - A J PARK Level 11 60 Marcus Clarke Street Canberra ACT 2601 2004

1 July 2010 Section 223 Application Allowed

Protemix Corporation Limited The time in which to gain acceptance has been extended to 19 Jul 2010. Address for service in Australia - A J PARK Level 11 60 Marcus Clarke Street Canberra ACT 2601 Extensions of Time, Section 223 2004

8 July 2010 Application Accepted

Published as AU-B-2003258909

4 November 2010 Standard Patent Sealed

16 June 2011 Assignment Registered

Protemix Corporation Limited The patent has been assigned to Philera New Zealand Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.